
Immutep Limited IMMP
Geschäftsbericht 2025
hinzugefügt 07.02.2026
Immutep Limited ROE 2011-2026 | IMMP
ROE Jährlich Immutep Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | -40.45 | -75.22 | -38.02 | -35.3 | -175.59 | -130.22 | -59.06 | -52.06 | -53.67 | - |
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -35.3 | -175.59 | -73.29 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | ||
|
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | ||
|
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
Adagene
ADAG
|
-66.16 | $ 3.0 | - | $ 169 M | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
AlloVir
ALVR
|
-51.87 | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.53 | - | $ 8.49 B | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
Aptose Biosciences
APTO
|
559.76 | - | -45.71 % | $ 1.2 M | ||
|
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | ||
|
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | ||
|
Athira Pharma
ATHA
|
-216.19 | - | - | $ 269 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-40.17 | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
-43.41 | - | -1.09 % | $ 5 B | ||
|
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | ||
|
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | ||
|
Brickell Biotech
BBI
|
-57.34 | - | -5.38 % | $ 6.06 M | ||
|
Arena Pharmaceuticals
ARNA
|
-91.56 | - | -6.81 % | $ 3.04 B | ||
|
Aridis Pharmaceuticals
ARDS
|
125.33 | - | 17.91 % | $ 11.1 M | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-270.67 | - | -10.17 % | $ 12.2 K | ||
|
BioNTech SE
BNTX
|
1.11 | $ 109.27 | - | $ 27.2 B | ||
|
Burford Capital Limited
BUR
|
10.1 | $ 9.09 | - | $ 1.46 B | ||
|
Athersys
ATHX
|
-531.22 | - | 3.77 % | $ 22.4 M | ||
|
Avenue Therapeutics
ATXI
|
-418.16 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
-51.64 | - | -0.7 % | $ 362 M | ||
|
Amneal Pharmaceuticals
AMRX
|
67.61 | $ 14.88 | 0.78 % | $ 4.6 B | ||
|
AIkido Pharma
AIKI
|
-36.89 | - | 1.93 % | $ 17.4 M | ||
|
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-144.96 | $ 4.38 | 0.81 % | $ 9.53 B | ||
|
BeiGene, Ltd.
BGNE
|
-19.35 | - | 0.49 % | $ 251 B | ||
|
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | ||
|
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | ||
|
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-71.51 | $ 2.32 | 0.43 % | $ 14.6 M | ||
|
AstraZeneca PLC
AZN
|
20.44 | - | - | $ 96.9 B | ||
|
Blueprint Medicines Corporation
BPMC
|
-22.46 | - | - | $ 8.14 B | ||
|
Atreca
BCEL
|
-123.92 | - | -11.76 % | $ 5.79 M |